Gilboa Therapeutics
Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology.
About
Technology stack
detected 2026-05-24No comments yet. Be the first to share your take.
What does Gilboa Therapeutics do?
Gilboa Therapeutics is a preclinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. Their mission is to enable more patients to respond to therapies and improve outcomes by harnessing the power of the patient's immune system with their proprietary SolidT technology.
How much funding has Gilboa Therapeutics raised?
Gilboa Therapeutics has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Gilboa Therapeutics headquartered?
Gilboa Therapeutics is headquartered in Tel Aviv, Israel.
When was Gilboa Therapeutics founded?
Gilboa Therapeutics was founded in 2017.
What industry does Gilboa Therapeutics operate in?
Gilboa Therapeutics operates in Biopharmaceuticals, Immunotherapy, Cancer Treatment, Biotechnology, Biotech, Drug Discovery.
How many employees does Gilboa Therapeutics have?
Gilboa Therapeutics has approximately 2 people on record.
What is Gilboa Therapeutics's current status?
Gilboa Therapeutics's current operating status is: Inactive.